🇺🇸 FDA
Patent

US 11926656

Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection

granted A61KA61K38/00A61P

Quick answer

US patent 11926656 (Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P31/22